The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes (NCT05337826)
Readiness, Education, and Sustainability for CGM Technology Adoption Model for Older Adults With Insulin-treated Diabetes
🩺 Plain-English Summary (8th-Grade Level)
To assess the efficacy of the REST model in facilitating adoption and sustained use of CGM, in older adults with Type 1 diabetes (T1D) or Type 2 Diabetes (T2D) on complex insulin regimens. To examine barriers and enablers for the implementation feasibility of the REST intervention model using a mixed-methods approach. To assess the impact of REST model on economic factors and quality of life measures. The goal of this study is to facilitate the adoption of continuous glucose monitoring (CGM) in older adults (≥65 years) with diabetes mellitus (DM) on complex insulin regimens, and additionally, to build a framework for sustained CGM use over time using a novel patient-centered model - the REST model.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (8 items) and avoid the listed exclusions (7 items).
Location: Joslin Diabetes Center — Boston, Massachusetts
Age range: 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Life expectancy \<1 year
- End-stage renal disease (eGFR\< 30ml/min)
- On acetaminophen \>4 gr/day due to interference with Dexcom G6 sensor readings
- On hydroxyurea therapy due to interference with Dexcom G6 sensor readings
- Impaired vision and hearing which would interfere with participation in remote video visits
- Use of hybrid closed-loop systems (this may require different and additional focused education and will not be addressed in this study).
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (2 Sites)
- Joslin Diabetes Center — Boston, Massachusetts
- SUNY Upstate Medical University — Syracuse, New York
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetes Mellitus
- Early Tracking of Childhood Health Determinants (ETCHED) Study — Phoenix, Arizona
- Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature — Escondido, California
- Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People — Emo, Ontario
- Effectiveness of an Inpatient Rehabilitation and Prosthetic Training Model in Patients With Vascular and Metabolic Transfemoral Amputation — Mexico City, Mexico City
- Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care — Gatineau,
Explore by condition: All Diabetes Mellitus clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.